Symbol="ACRX"
AssetType="Common Stock"
Name="AcelRx Pharmaceuticals Inc"
Description="AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. The company is headquartered in Redwood City, California."
CIK="1427925"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="351 GALVESTON DRIVE, REDWOOD CITY, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="16037200"
EBITDA="-30424000"
PERatio="0.155"
PEGRatio="0"
BookValue="1.304"
DividendPerShare="0"
DividendYield="0"
EPS="6.36"
RevenuePerShareTTM="0.214"
ProfitMargin="24.2"
OperatingMarginTTM="-18.11"
ReturnOnAssetsTTM="-0.408"
ReturnOnEquityTTM="0"
RevenueTTM="1771000"
GrossProfitTTM="-5030000"
DilutedEPSTTM="6.36"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="125"
AnalystTargetPrice="4"
TrailingPE="0.155"
ForwardPE="1.06"
PriceToSalesRatioTTM="11.8"
PriceToBookRatio="0.69"
EVToRevenue="10.28"
EVToEBITDA="0.309"
Beta="0.256"
num_52WeekHigh="7.6"
num_52WeekLow="0.55"
num_50DayMovingAverage="1.098"
num_200DayMovingAverage="1.544"
SharesOutstanding="16264900"
DividendDate="None"
ExDividendDate="None"
symbol="ACRX"
open="0.95"
high="0.99"
low="0.94"
price="0.95"
volume="74296.00"
latest_trading_day="2023-08-08"
previous_close="0.95"
change="-0.00"
change_percent="-0.4193%"
aroon_positive_momentum_days="46"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="46"
Volume_recent_avg="149189"
Change_recent_avg="0.01"
Delta_recent_avg="0.09"
Variance_recent_avg="0.04"
Change_ratio_recent_avg="-0.3"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="46"
Aroon_momentum_negative="54"
image_negative_thumbnail_id_1="106"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0070.jpeg"
image_negative_thumbnail_id_2="517"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0088.jpeg"
image_neutral_thumbnail_id_1="534"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0065.jpeg"
image_neutral_thumbnail_id_2="555"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0044.jpeg"
image_positive_thumbnail_id_1="691"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0017.jpeg"
image_positive_thumbnail_id_2="648"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0060.jpeg"
image_professor_thumbnail_id_1="1187"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0021.jpeg"
image_professor_thumbnail_id_2="1193"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0027.jpeg"
